P2X7 polymorphisms and stem cell mobilisation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential.Purinergic signalling · 2025
   Review
2. P2X7 Variants in Pathophysiology.International journal of molecular sciences · 2024
   Review
3. The P2X7 receptor is a target of p53 and regulates haematopoiesis following radiation-induced genotoxic stress.Purinergic signalling · 2022
   Article
4. Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease.Methods in molecular biology (Clifton, N.J.) · 2022
   Article
5. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking.Leukemia · 2022
   Article
6. p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress.Cell death & disease · 2021
   Article
7. Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease.International journal of molecular sciences · 2021
   Review
8. P2X7 Receptor in Hematological Malignancies.Frontiers in cell and developmental biology · 2021
   Review
9. Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.Purinergic signalling · 2020
   Review
10. An Overview of Novel Unconventional Mechanisms of Hematopoietic Development and Regulators of Hematopoiesis - a Roadmap for Future Investigations.Stem cell reviews and reports · 2019
    Review

Corrections and comments

• Comment on
  Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells.2018

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.